Developments ME secures U.S. patent for lead G-CSF antibody candidate Me Therapeutics Holdings (CSE: METX; FSE: Q9T) has announced that the United States Patent Office (USPTO) has granted its subsidiary, ME Therapeutics, a patent for its lead G-CSF antibody candidate. According to ME, the... September 26, 2025